ArticleGene therapy2026

Preclinical safety and biodistribution of SPVN06, a novel gene- and mutation-independent gene therapy for rod-cone dystrophies.

Mélanie Marie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.